3CM

RLX TECH. SP.ADR/1 CL.A

Consumer Defensive · EUR · F

3CM

Price

€1.764

-2.60%

Cap

€2.57B

Earnings

30d Trend

-5.5%

3CM
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

33% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level55
Quality17
Momentum51
Technical40
Fundamentals35

Raw weighted: 37×Macro 0.99 (1%)=37

RISK

55/100
90d Volatility
32.7%Moderate
ATR %
4.4%High daily moves
Max Drawdown (1Y)
-24.0%Normal

QUALITY

17/100
ROE (avg)
3.5%Weak
Piotroski F-Score
1/9Weak

MOMENTUM

51/100
12-1M Momentum
+10.4%Strong uptrend
6-1M Momentum
-10.5%Negative
1M Return
-5.1%Recent pullback
Relative Strength
+0.4% vs sectorIn-line

TECHNICAL

40/100
RSI (14)
41.3Neutral
Price vs SMA200
-10.6%Bearish trend
MACD
-0.02Bearish momentum
Bollinger Band
8%Near lower band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.133Noisy/choppy

FUNDAMENTALS

35/100
P/S
8.8Expensive

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months38
3-12 months29
1-5+ years37

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate RLX TECH. SP.ADR/1 CL.A at 37/100 — a WEAK reading on the Brain47 Signal. The strongest factor is momentum at 51/100. I classify this as a growth position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

-5.1%

3 MONTHS

-16.1%

12 MONTHS

+5.3%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Momentum (51) and low-risk profile are the primary strengths. I note that quality is the weakest area at 17/100 — this warrants monitoring. Historical volatility is moderate at 33%. I classify this as a growth position — positive trend direction combined with growth potential points to capital appreciation.

growthScore: 37/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.